Engineered protein nanoparticles for invivo tumor detection

Biomaterials

Volumn 35, Issue 24, 2014, Pages 6422-6429

  Ahn, Keum Young ^a   Ko, Ho Kyung ^b,c   Lee, Bo Ram ^a   Lee, Eun Jung ^a   Lee, Jong Hwan ^a   Byun, Youngro ^c   Kwon, Ick Chan ^b   Kim, Kwangmeyung ^b   Lee, Jeewon ^a  

^a Korea University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Optical imaging; Protein nanoparticles; Surface engineering; Tumor detection

Indexed keywords

AMINO ACIDS; ESCHERICHIA COLI; FLUORESCENCE; NANOPARTICLES; PEPTIDES; SURFACE STRUCTURE;

ACIDOPHILIC BACTERIA; ARGININE-GLYCINE-ASPARTIC ACIDS; FLUORESCENCE INTENSITIES; NEAR-INFRARED FLUORESCENCE; OPTICAL IMAGING; PROTEIN NANOPARTICLES; SURFACE ENGINEERING; TUMOR DETECTION;

TUMORS;

ESCHERICHIA COLI PROTEIN; NANOPARTICLE; PROTEASOME;

ANIMAL; CELL DEATH; CHEMICAL STRUCTURE; CHEMISTRY; DIAGNOSTIC IMAGING; DRUG EFFECTS; HUMAN; METABOLISM; NEAR INFRARED SPECTROSCOPY; NEOPLASMS; NUDE MOUSE; PROTEIN ENGINEERING; SUBCUTANEOUS TISSUE; THERMOPLASMA; TISSUE DISTRIBUTION; TOXICITY; TUMOR CELL LINE;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; DIAGNOSTIC IMAGING; ESCHERICHIA COLI PROTEINS; HUMANS; MICE, NUDE; MODELS, MOLECULAR; NANOPARTICLES; NEOPLASMS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN ENGINEERING; SPECTROSCOPY, NEAR-INFRARED; SUBCUTANEOUS TISSUE; THERMOPLASMA; TISSUE DISTRIBUTION;

EID: 84901398232     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.04.041     Document Type: Article

References (35)

1. Gindy M.E., Prud'homme R.K. Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. Expert Opin Drug Deliv 2009, 6:865-878.
2. McCarthy J.R. Multifunctional agents for concurrent imaging and therapy in cardiovascular disease. Adv Drug Deliv Rev 2010, 62:1023-1030.
3. Bagwe R.P., Hilliard L.R., Tan W. Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. Langmuir 2006, 22:4357-4362.
4. Sperling R.A., Parak W.J. Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos Trans A Math Phys Eng Sci 2010, 368:1333-1383.
5. Ahn J.Y., Choi H., Kim Y.H., Han K.Y., Park J.S., Han S.S., et al. Heterologous gene expression using self-assembled supra-molecules with high affinity for HSP70 chaperone. Nucleic Acids Res 2005, 33:3751-3762.
6. Park J.S., Cho M.K., Lee E.J., Ahn K.Y., Lee K.E., Jung J.H., et al. Ahighly sensitive and selective diagnostic assay based on virus nanoparticles. Nat Nanotechnol 2009, 4:259-264.
7. Lee S.H., Lee H., Park J.S., Choi H., Han K.Y., Seo H.S., et al. Anovel approach to ultrasensitive diagnosis using supramolecular protein nanoparticles. FASEB J 2007, 21:1324-1334.
8. Lee E.J., Ahn K.Y., Lee J.H., Park J.S., Song J.A., Sim S.J., et al. Anovel bioassay platform using ferritin-based nanoprobe hydrogel. Adv Mater 2012, 24:4739-4744.
9. Seo H.S., Kim S.E., Park J.S., Lee J.H., Yang K.Y., Lee H., et al. Athree-dimensional nanostructured array of protein nanoparticles. Adv Funct Mater 2010, 20:4055-4061.
10. Lee J.H., Kim J.S., Park J.S., Lee W., Lee K.E., Han S.S., et al. Athree-dimensional and sensitive bioassay based on nanostructured quartz combined with viral nanoparticles. Adv Funct Mater 2010, 20:2004-2009.
11. Lee J.H., Seo H.S., Song J.A., Kwon K.C., Lee E.J., Kim H.J., et al. Proteinticle engineering for accurate 3D diagnosis. ACS Nano 2013, 7:10879-10886.
12. Yoo L., Park J.S., Kwon K.C., Kim S.E., Jin X., Kim H., et al. Fluorescent viral nanoparticles with stable invitro and invivo activity. Biomaterials 2012, 33:6194-6200.
13. Li X., Qiu L., Zhu P., Tao X., Imanaka T., Zhao J., et al. Epidermal growth factor-ferritin H-chain protein nanoparticles for tumor active targeting. Small 2012, 8:2505-2514.
14. Ceci P., Cellai S., Falvo E., Rivetti C., Rossi G.L., Chiancone E. DNA condensation and self-aggregation of Escherichia coli Dps are coupled phenomena related to the properties of the N-terminus. Nucleic Acids Res 2004, 32:5935-5944.
15. Grant R.A., Filman D.J., Finkel S.E., Kolter R., Hogle J.M. The crystal structure of Dps, a ferritin homolog that binds and protects DNA. Nat Struct Biol 1998, 5:294-303.
16. Beadell J.S., Clark D.S. Probing stability-activity relationships in the thermophilic proteasome from Thermoplasma acidophilum by random mutagenesis. Extremophiles 2001, 5:3-10.
17. Löwe J., Stock D., Jap B., Zwickl P., Baumeister W., Huber R. Crystal structure of the 20S proteasome from the archaeon T. acidophilum at 3.4 A resolution. Science 1995, 268:533-539.
18. Marelli U.K., Rechenmacher F., Sobahi T.R., Mas-Moruno C., Kessler H. Tumor targeting via integrin ligands. Front Oncol 2013, 30:222.
19. Longmire M.R., Ogawa M., Choyke P.L., Kobayashi H. Biologically optimized nanosized molecules and particles: more than just size. Bioconjug Chem 2011, 22:993-1000.
20. Wang J., Sui M., Fan W. Nanoparticles for tumor targeted therapies and their pharmacokinetics. Curr Drug Metab 2010, 11:129-141.
21. Choi J., Wang N.S. Nanoparticles in biomedical applications and their safety concerns. Biomedical engineering - from theory to applications 2011, 299-314. InTech, Rijeka. R. Fazel-Rezai (Ed.).
22. Elsaesser A., Howard C.V. Toxicology of nanoparticles. Adv Drug Deliv Rev 2012, 64:129-137.
23. Maham A., Tang Z., Wu H., Wang J., Lin Y. Protein-based nanomedicine platforms for drug delivery. Small 2009, 5:1706-1721.
24. Fotakis G., Timbrell J.A. Invitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. Toxicol Lett 2006, 160:171-177.
25. Cheng Z., Wu Y., Xiong Z., Gambhir S.S., Chen X. Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice. Bioconjug Chem 2005, 16:1433-1441.
26. Huang R., Vider J., Kovar J.L., Olive D.M., Mellinghoff I.K., Mayer-Kuckuk P., et al. Integrin αvβ3-targeted IRDye 800CW near-infrared imaging of glioblastoma. Clin Cancer Res 2012, 18:5731-5740.
27. Albanese A., Tang P.S., Chan W.C. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng 2012, 14:1-16.
28. Meibohm B. Pharmacokinetics and half-life of protein therapeutics. Therapeutic proteins: strategies to modulate theirplasma half-lives 2012, 23-38. Wiley-VCH Verlag GmbH & Co, Weinheim. R. Kontermann (Ed.).
29. Shevtsov M.A., Shatik S.V., Tokarev, Mostova M.I., Tiutin L.A., Bychkova N.V., et al. Biodistribution of the recombinant heat shock protein rhHsp70 in intracranial C6 glioma models in wistar rats and subcutaneos B16/F10 melanoma in C57BL/6 mice. Vopr Onkol 2013, 59:78-83.
30. Kaiser C.R., Flenniken M.L., Gillitzer E., Harmsen A.L., Harmsen A.G., Jutila M.A., et al. Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance invivo. Int J Nanomed 2007, 2:715-733.
31. Singh P., Prasuhn D., Yeh R.M., Destito G., Rae C.S., Osborn K., et al. Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles invivo. JControl Release 2007, 120:41-50.
32. Sadauskas E., Wallin H., Stoltenberg M., Vogel U., Doering P., Larsen A., et al. Kupffer cells are central in the removal of nanoparticles from the organism. Part Fibre Toxicol 2007, 4:10-16.
33. Arnida, Janát-Amsbury M.M., Ray A., Peterson C.M., Ghandehari H. Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages. Eur J Pharm Biopharm 2011, 77:417-423.
34. Gratton S.E., Ropp P.A., Pohlhaus P.D., Luft J.C., Madden V.J., Napier M.E., et al. The effect of particle design on cellular internalization pathways. Proc Natl Acad Sci U S A 2008, 105:11613-11618.
35. Hillaireau H., Couvreur P. Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci 2009, 66:2873-2896.